Expanding indications of non-vitamin K oral anticoagulants beyond non-valvular atrial fibrillation and venous thromboembolism: a review of emerging clinical …
Anticoagulation options have expanded over the last few decades, providing a greater
variety of medications for thromboembolic disease prevention and management. Direct oral …
variety of medications for thromboembolic disease prevention and management. Direct oral …
Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical …
A Hajra, A Ujjawal, N Ghalib… - Current Problems in …, 2024 - touroscholar.touro.edu
Direct oral anticoagulants (DOAC) have emerged as a new therapy for patients who need
and can tolerate oral anticoagulation. DOACs were initially approved for nonvalvular atrial …
and can tolerate oral anticoagulation. DOACs were initially approved for nonvalvular atrial …
[引用][C] Expanding indications of non-vitamin K oral anticoagulants beyond non-valvular atrial fibrillation and venous thromboembolism: a review of emerging clinical …
A Hajra, A Ujjawal, N Ghalib, S Chowdhury… - Current Problems in …, 2023 - europepmc.org
Expanding indications of non-vitamin K oral anticoagulants beyond non-valvular atrial fibrillation
and venous thromboembolism: a review of emerging clinical evidence. - Abstract - Europe …
and venous thromboembolism: a review of emerging clinical evidence. - Abstract - Europe …
[引用][C] Expanding indications of non-vitamin K oral anticoagulants beyond non-valvular atrial fibrillation and venous thromboembolism: a review of emerging clinical …
A Hajra, A Ujjawal, N Ghalib… - Current problems in … - pubmed.ncbi.nlm.nih.gov
Expanding indications of non-vitamin K oral anticoagulants beyond non-valvular atrial fibrillation
and venous thromboembolism: a review of emerging clinical evidence Expanding indications of …
and venous thromboembolism: a review of emerging clinical evidence Expanding indications of …